Provide high-quality, efficient, convenient, and innovative medical solutions in the field of eye health for global users.
With the aging population and overuse of electronic products, the number of people with eye diseases has been increasing year by year. Myopia is particularly prevalent among young people, and the age of onset is decreasing. In 2017, the global ophthalmic surgery market was about 9 billion USD, and the vision care market was about 14 billion USD. The compound annual growth rate is expected to be 4% from 2018 to 2023, and the current global ophthalmology market size exceeds 50 billion USD. The myopia prevention and control market in China is the fastest-growing segment in recent years, with a terminal scale of about 66.6 billion yuan in 2021, and is expected to reach 120 billion yuan in 2025.
The product layout of Nthoptic is based on the professional field of ophthalmic consumer medical products. It not only has a myopia prevention and control product line, but also has wearable devices for dry eye syndrome, digital eye and vision peripherals, and other product layouts. The first S.T.O.P KIT, which landed, upgraded the principle of myopia prevention and control and made innovations in design and product form, bringing a breakthrough in global technological innovation to this segmented and essential demand path of myopia prevention and control.
The research and development team has rich experience in science, medicine, engineering, optical vision, and enterprise management, and has multiple successful cases in product commercialization. The core management team has cooperated for many years and has abundant resources in Australian universities and the medical industry. The company's founding team has been deeply engaged in the field of ophthalmology for more than 15 years and has worked for top ophthalmic foreign companies such as Carl Zeiss and Alcon, with rich experience and resources in marketing, clinical, sales, and channels.
【Scan and follow us】
